RPA194 Antibodies

Santa Cruz Biotechnology provides a broad selection of RPA194 monoclonal antibodies for advanced research in molecular biology. RPA194 monoclonal antibodies are validated for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). RPA194, a subunit of RNA polymerase I, plays a critical role in the transcription of ribosomal RNA, which is essential for ribosome biogenesis and protein synthesis. Its proper function is vital for cellular growth and proliferation, making RPA194 an important target for studies related to cancer and other diseases characterized by dysregulated cell growth. Understanding the dynamics of RPA194 can provide insights into the mechanisms of transcription regulation and its implications in various biological processes. RNA polymerase I activity influences numerous cellular pathways and developmental stages. Researchers studying RPA194 can uncover new connections between transcriptional control and disease progression. Investigating RPA194 function helps illuminate the complex relationship between ribosomal RNA synthesis and cell cycle regulation. Santa Cruz Biotechnology monoclonal antibodies for RPA194 enable researchers worldwide to advance our understanding of fundamental cellular processes and potential therapeutic targets.